Table 5.
Patient-Based Analysis of Treatment Response After First DEB-TACE Therapy
| Items | Total Patients (N=286) | VL Patients (n=49) | Non-VL Patients (n=237) | P value |
|---|---|---|---|---|
| Total response | 0.002 | |||
| CR, No. (%) | 53 (18.5) | 10 (20.4) | 43 (18.2) | |
| PR, No. (%) | 137 (47.9) | 35 (71.4) | 102 (43.0) | |
| SD, No. (%) | 60 (21.0) | 3 (6.2) | 57 (24.0) | |
| PD, No. (%) | 36 (12.6) | 1 (2.0) | 35 (14.8) | |
| ORR, No. (%) | 190 (66.4) | 45 (91.8) | 145 (61.2) | <0.001 |
| DCR, No. (%) | 250 (87.4) | 48 (98.0) | 202 (85.2) | 0.014 |
Note: Comparison was determined by Wilcoxon rank test or Chi-square test.
Abbreviations: DEB-TACE, drug-eluting beads transarterial chemoembolization; VL, vascular lake; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate.